Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.

[1]  E. Petricoin,et al.  Proteomics of human breast ductal carcinoma in situ. , 2002, Cancer research.

[2]  E. Petricoin,et al.  Clinical proteomics: translating benchside promise into bedside reality , 2002, Nature Reviews Drug Discovery.

[3]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[4]  Thomas P Conrads,et al.  The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. , 2002, Biochemical and biophysical research communications.

[5]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[6]  H. Moch,et al.  Tissue microarrays for rapid linking of molecular changes to clinical endpoints. , 2001, The American journal of pathology.

[7]  T. Barrette,et al.  Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. , 2001, Cancer research.

[8]  L. Liotta,et al.  Proteomic profiling of the cancer microenvironment by antibody arrays , 2001, Proteomics.

[9]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[10]  G. Wright,et al.  Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. , 2001, The American journal of pathology.

[11]  B. Chait,et al.  Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome , 2001, Nature Biotechnology.

[12]  B. Cravatt,et al.  Profiling serine hydrolase activities in complex proteomes. , 2001, Biochemistry.

[13]  L. Spremulli,et al.  Identification of four proteins from the small subunit of the mammalian mitochondrial ribosome using a proteomics approach , 2001, Protein science : a publication of the Protein Society.

[14]  L. Liotta,et al.  The role of tissue microdissection in cancer research. , 2001, Cancer journal.

[15]  B. Cravatt,et al.  Profiling the specific reactivity of the proteome with non-directed activity-based probes. , 2001, Chemistry & biology.

[16]  F. Rudert,et al.  Genomics and proteomics tools for the clinic. , 2000, Current opinion in molecular therapeutics.

[17]  G I Murray,et al.  Proteomics: a new approach to the study of disease , 2000, The Journal of pathology.

[18]  H. Davies,et al.  Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. , 2000, BioTechniques.

[19]  M. Fivaz,et al.  Analysis of glycosyl phosphatidylinositol‐anchored proteins by two‐dimensional gel electrophoresis , 2000, Electrophoresis.

[20]  Mary F. Lopez,et al.  High‐throughput profiling of the mitochondrial proteome using affinity fractionation and automation , 2000, Electrophoresis.

[21]  S. Hanash.  Operomics: Molecular Analysis of Tissues from DNA to RNA to Protein , 2000, Clinical chemistry and laboratory medicine.

[22]  T. Ørntoft,et al.  Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics , 2000, FEBS letters.

[23]  J. Skehel,et al.  Analysis of N-linked oligosaccharides released from glycoproteins separated by two-dimensional gel electrophoresis. , 2000, Analytical biochemistry.

[24]  C. Desponts,et al.  A general method for the rapid characterization of tyrosine‐phosphorylated proteins by mini two‐dimensional gel electrophoresis , 2000, Electrophoresis.

[25]  F. Witzmann,et al.  Proteomics: Applications and opportunities in preclinical drug development , 2000, Electrophoresis.

[26]  E. Petricoin,et al.  Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines , 2000, Electrophoresis.

[27]  S. Weinberger,et al.  Recent advancements in surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry , 2000, Electrophoresis.

[28]  C. Nilsson,et al.  Use of an affinity proteomics approach for the identification of low‐abundant bacterial adhesins as applied on the Lewisb‐binding adhesin of Helicobacter pylori , 2000, FEBS letters.

[29]  G A Petsko,et al.  Chemistry and biology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Ng,et al.  Chromophore‐assisted laser inactivation (CALI) to validate drug targets and pharmacogenomic markers , 2000 .

[31]  E. Petricoin,et al.  Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip , 2000 .

[32]  Federico Brianza,et al.  Functional proteomics of signal transduction by membrane receptors , 1999, Electrophoresis.

[33]  D. Pappin,et al.  The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis — Preliminary findings , 1999, Electrophoresis.

[34]  L. Liotta,et al.  Laser Capture Microdissection , 1996, Science.

[35]  T. Yip,et al.  New desorption strategies for the mass spectrometric analysis of macromolecules , 1993 .